Transplanted Human Neural Progenitor Cells Attenuate Motor Dysfunction and Lengthen Longevity in a Rat Model of Ataxia

The spastic Han Wistar (sHW) rat serves as a model for human ataxia presenting symptoms of motor deterioration, weight loss, shortened lifespan, and Purkinje neuron loss. Past studies revealed that human neural progenitor cells (NPCs) improved ataxic symptoms at 20 d posttransplantation in sHW rats....

Full description

Bibliographic Details
Main Authors: Wesley M. Tierney, Toni L. Uhlendorf, Aaron J.J. Lemus, Bianca A. Ortega, Jesse Magaña, Jessica Ochoa, William Van Trigt, Angelica Cruz, Alex Kopyov, Oleg V. Kopyov, Randy W. Cohen
Format: Article
Language:English
Published: SAGE Publishing 2020-04-01
Series:Cell Transplantation
Online Access:https://doi.org/10.1177/0963689720920275
_version_ 1828907504606642176
author Wesley M. Tierney
Toni L. Uhlendorf
Aaron J.J. Lemus
Bianca A. Ortega
Jesse Magaña
Jessica Ochoa
William Van Trigt
Angelica Cruz
Alex Kopyov
Oleg V. Kopyov
Randy W. Cohen
author_facet Wesley M. Tierney
Toni L. Uhlendorf
Aaron J.J. Lemus
Bianca A. Ortega
Jesse Magaña
Jessica Ochoa
William Van Trigt
Angelica Cruz
Alex Kopyov
Oleg V. Kopyov
Randy W. Cohen
author_sort Wesley M. Tierney
collection DOAJ
description The spastic Han Wistar (sHW) rat serves as a model for human ataxia presenting symptoms of motor deterioration, weight loss, shortened lifespan, and Purkinje neuron loss. Past studies revealed that human neural progenitor cells (NPCs) improved ataxic symptoms at 20 d posttransplantation in sHW rats. In this study, we investigated the fate and longer-term effectiveness of these transplanted NPCs. Rats were placed into four treatment groups: an untreated normal control group ( n = 10), an untreated mutant rat control ( n = 10), a mutant group that received an injection of dead NPCs ( n = 9), and a mutant group that received live NPCs ( n = 10). Bilateral cerebellar injections containing 500,000 of either live or dead NPCs were performed on mutant sHW rats at 40 d of age. Motor activity for all mutant rats started to decline in open field testing around day 35. However, at day 45, the live NPC-treated mutants exhibited significant improvements in open field activity. Similar improvements were observed during rotarod testing and weight gain through the completion of the experiments (100 d). Immunohistochemistry revealed few surviving human NPCs in the cerebella of 80- and 100-d-old NPC-treated mutants; while cresyl violet staining revealed that live NPC-treated mutants had significantly more surviving Purkinje neurons compared to mutants that were untreated or received dead NPCs. Direct stereotactic implantation of NPCs alleviated the symptoms of ataxia, acting as a neuroprotectant, supporting future clinical applications of these NPCs in the areas of ataxia as well as other neurodegenerative diseases.
first_indexed 2024-12-13T17:53:46Z
format Article
id doaj.art-f98e01d0561b4ba7be40a22ae64194ad
institution Directory Open Access Journal
issn 1555-3892
language English
last_indexed 2024-12-13T17:53:46Z
publishDate 2020-04-01
publisher SAGE Publishing
record_format Article
series Cell Transplantation
spelling doaj.art-f98e01d0561b4ba7be40a22ae64194ad2022-12-21T23:36:25ZengSAGE PublishingCell Transplantation1555-38922020-04-012910.1177/0963689720920275Transplanted Human Neural Progenitor Cells Attenuate Motor Dysfunction and Lengthen Longevity in a Rat Model of AtaxiaWesley M. Tierney0Toni L. Uhlendorf1Aaron J.J. Lemus2Bianca A. Ortega3Jesse Magaña4Jessica Ochoa5William Van Trigt6Angelica Cruz7Alex Kopyov8Oleg V. Kopyov9Randy W. Cohen10 Department of Biology, California State University, Northridge, CA, USA Department of Biology, California State University, Northridge, CA, USA Department of Biology, California State University, Northridge, CA, USA Department of Biology, California State University, Northridge, CA, USA Department of Biology, California State University, Northridge, CA, USA Celavie Biosciences, LLC, Oxnard, CA, USA Celavie Biosciences, LLC, Oxnard, CA, USA Celavie Biosciences, LLC, Oxnard, CA, USA Celavie Biosciences, LLC, Oxnard, CA, USA Celavie Biosciences, LLC, Oxnard, CA, USA Department of Biology, California State University, Northridge, CA, USAThe spastic Han Wistar (sHW) rat serves as a model for human ataxia presenting symptoms of motor deterioration, weight loss, shortened lifespan, and Purkinje neuron loss. Past studies revealed that human neural progenitor cells (NPCs) improved ataxic symptoms at 20 d posttransplantation in sHW rats. In this study, we investigated the fate and longer-term effectiveness of these transplanted NPCs. Rats were placed into four treatment groups: an untreated normal control group ( n = 10), an untreated mutant rat control ( n = 10), a mutant group that received an injection of dead NPCs ( n = 9), and a mutant group that received live NPCs ( n = 10). Bilateral cerebellar injections containing 500,000 of either live or dead NPCs were performed on mutant sHW rats at 40 d of age. Motor activity for all mutant rats started to decline in open field testing around day 35. However, at day 45, the live NPC-treated mutants exhibited significant improvements in open field activity. Similar improvements were observed during rotarod testing and weight gain through the completion of the experiments (100 d). Immunohistochemistry revealed few surviving human NPCs in the cerebella of 80- and 100-d-old NPC-treated mutants; while cresyl violet staining revealed that live NPC-treated mutants had significantly more surviving Purkinje neurons compared to mutants that were untreated or received dead NPCs. Direct stereotactic implantation of NPCs alleviated the symptoms of ataxia, acting as a neuroprotectant, supporting future clinical applications of these NPCs in the areas of ataxia as well as other neurodegenerative diseases.https://doi.org/10.1177/0963689720920275
spellingShingle Wesley M. Tierney
Toni L. Uhlendorf
Aaron J.J. Lemus
Bianca A. Ortega
Jesse Magaña
Jessica Ochoa
William Van Trigt
Angelica Cruz
Alex Kopyov
Oleg V. Kopyov
Randy W. Cohen
Transplanted Human Neural Progenitor Cells Attenuate Motor Dysfunction and Lengthen Longevity in a Rat Model of Ataxia
Cell Transplantation
title Transplanted Human Neural Progenitor Cells Attenuate Motor Dysfunction and Lengthen Longevity in a Rat Model of Ataxia
title_full Transplanted Human Neural Progenitor Cells Attenuate Motor Dysfunction and Lengthen Longevity in a Rat Model of Ataxia
title_fullStr Transplanted Human Neural Progenitor Cells Attenuate Motor Dysfunction and Lengthen Longevity in a Rat Model of Ataxia
title_full_unstemmed Transplanted Human Neural Progenitor Cells Attenuate Motor Dysfunction and Lengthen Longevity in a Rat Model of Ataxia
title_short Transplanted Human Neural Progenitor Cells Attenuate Motor Dysfunction and Lengthen Longevity in a Rat Model of Ataxia
title_sort transplanted human neural progenitor cells attenuate motor dysfunction and lengthen longevity in a rat model of ataxia
url https://doi.org/10.1177/0963689720920275
work_keys_str_mv AT wesleymtierney transplantedhumanneuralprogenitorcellsattenuatemotordysfunctionandlengthenlongevityinaratmodelofataxia
AT toniluhlendorf transplantedhumanneuralprogenitorcellsattenuatemotordysfunctionandlengthenlongevityinaratmodelofataxia
AT aaronjjlemus transplantedhumanneuralprogenitorcellsattenuatemotordysfunctionandlengthenlongevityinaratmodelofataxia
AT biancaaortega transplantedhumanneuralprogenitorcellsattenuatemotordysfunctionandlengthenlongevityinaratmodelofataxia
AT jessemagana transplantedhumanneuralprogenitorcellsattenuatemotordysfunctionandlengthenlongevityinaratmodelofataxia
AT jessicaochoa transplantedhumanneuralprogenitorcellsattenuatemotordysfunctionandlengthenlongevityinaratmodelofataxia
AT williamvantrigt transplantedhumanneuralprogenitorcellsattenuatemotordysfunctionandlengthenlongevityinaratmodelofataxia
AT angelicacruz transplantedhumanneuralprogenitorcellsattenuatemotordysfunctionandlengthenlongevityinaratmodelofataxia
AT alexkopyov transplantedhumanneuralprogenitorcellsattenuatemotordysfunctionandlengthenlongevityinaratmodelofataxia
AT olegvkopyov transplantedhumanneuralprogenitorcellsattenuatemotordysfunctionandlengthenlongevityinaratmodelofataxia
AT randywcohen transplantedhumanneuralprogenitorcellsattenuatemotordysfunctionandlengthenlongevityinaratmodelofataxia